Skip to main content
. 2014 Jun 18;9(6):e99886. doi: 10.1371/journal.pone.0099886

Figure 1. Kaplan-Meier curves showing the association between overall survival and pre-treatment miRNA expression in whole blood from patients with metastatic colorectal cancer treated with 3rd line cetuximab and irinotecan.

Figure 1

Patients were dichotomized by the median expression value for miR-345. Low miRNA expression (red) and high miRNA expression (blue). The P-value refers to the Wald test.